Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000;32(1):77-9.
doi: 10.1023/a:1007164319067.

'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate

I Cervenákov  1 , M Kopecný, M Jancár, D Chovan, M Mal'a
Affiliations

'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate

I Cervenákov et al. Int Urol Nephrol. 2000.

Abstract

From 1995 to 1997 the authors have assessed 31 patients with histologically verified advanced carcinoma of the prostate (CaP) and the ensuing symptom of 'hot flush'. Patients underwent transurethral resection of the prostate (TURP), bilateral orchiectomy (OE) and combined androgen blockade (CAB) by the administration of non-steroid antiadrogens. The authors present the mechanism of the genesis of the 'hot flush' symptom as well as its subjective manifestations, methods of laboratory monitoring as well as their experience with the treatment of this symptom. 50 mg tablets cyproterone acetate administered twice daily or Androcur depot 300 mg i.m. inj. once in 14 days were the main factors in the treatment of 'hot flushes' which reduced subjective difficulties in 80.6% of the patients studied.

PubMed Disclaimer

References

    1. Cancer. 1993 Sep 1;72(5):1685-91 - PubMed
    1. J Urol. 1994 Jul;152(1):132-4 - PubMed
    1. Eur Urol. 1996;29(1):47-54 - PubMed
    1. Eur Urol. 1995;28(3):177-88 - PubMed
    1. Acta Urol Belg. 1994 Apr;62(1):77-82 - PubMed

LinkOut - more resources